We are taking early registrations for this fantastic event. Simply download this form and send it back to firstname.lastname@example.org to fast track your attendance to this industry-leading event!
Christopher Reed, Senior Counsel, Content Protection Policy at Fox Entertainment Group, covers contributing factors to growth of counterfeiting, payment processors as red flags, cooperative approaches to brand protection, and more.
Matt Sample, from AmerisourceBergen, describes his experiences using DSCSA Serialization and Pilot Programs inside his organization in regards to traceability.
Is your company contemplating the best strategies to reduce the threat of counterfeiting? Learn about how Lexmark halted these threats with serialization, authentication, and a track and trace strategy through its partnership with Verify Brand!
Global counterfeiting is on the rise for a variety of industries, not just pharmaceuticals. This infographic details some of the most high-profile counterfeit goods seizures in recent years, and weighs them against the staggering global scope of the issue - the battles yet to be fought.
Justin Pierce, Partner at Venable, and Cynthia Tregillis, Senior Director, Brand Protection & Trademark Law at Western Digital, go into preventative measures for Border & Customs, the Dark Web, Grey Markets, and more in this presentation.
Please complete the fields below to receive your copy of the 7th Pharma Anti-Counterfeiting & Brand Protection Summit prospectus which includes:
Sponsorship Opportunities | Attendee Profile | Sponsorship Packages
Present your manager with this customizable letter detailing the reasons why you should attend the upcoming event and you'll be sure to receive approval.
Detailed is an abbreviated list of Anti-Counterfeiting executives who attended the last iteration of the event. Will you be there to see what they experienced?
Please complete the fields below to receive your copy of the 6th Pharma Anti-Counterfeiting & Brand Protection Summit Attendee Snapshot.
Developing countries are the worst affected from counterfeit pharmaceuticals, regulatory structures are weaker and measurement and oversight is difficult. According to the World Health Organization, an estimated 1 in 10 medical products in low- and middle-income countries is substandard or falsified. This heat map specifically focuses in on the largest counterfeiting markets: Africa, China, and India. Download this map to learn about the latest advancements developing countries have taken in 2017 to combat anti-counterfeiting and which country needs to start making it a priority.
Prior to the Anti-Counterfeiting in Pharma & Brand Protection Summit in March, we sat down for an interview with Brian Files to discuss the largest challenges and implications in integrating serialization into the supply chain, what 2024 and beyond will look like, how new technologies will affect us, the major issues anticipated after the 2018 goal is met and more. Brian is a Principal Consultant at Healthcare Strategies Consulting Group and was formerly the Supply Chain Policy and Compliance Director at CVS Health.
In this current attendee snapshot, you will find the titles and companies of those who lead anti-counterfeiting efforts and who have signed up to be in attendance. Will you be joining them?